Optimal molecular binding data and pharmacokinetic profiles of novel potential triple-action inhibitors of chymase, spleen tyrosine kinase, and prostaglandin D2 receptor in the treatment of asthma
Journal of Genetic Engineering and Biotechnology · Volume 21, Issue 1 (2023) · pp. 113
Abstract
No abstract